Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents mixed signals. Financial performance shows declines in core EPS and net income, but there is growth in gross commitments and total portfolio value. The company maintains strong liquidity and a stable dividend, but lacks a share repurchase program. The Q&A reveals minimal exposure to tariffs and a strong dividend outlook, yet management's unclear responses on certain risks raise concerns. Overall, these factors suggest a neutral sentiment, with no strong catalysts for significant stock price movement in the short term.
Core Earnings Per Share (Core EPS) $0.50 (down from $0.59 year-over-year, down from $0.55 quarter-over-quarter); decline attributed to lower portfolio yields due to decreased average market base rates.
GAAP Net Income Per Share $0.60 (down from $0.76 year-over-year, down from $0.55 quarter-over-quarter); decline attributed to lower portfolio yields.
Gross Commitments $3,500,000,000 (up 54% year-over-year); increase due to active investing despite market volatility.
Total Portfolio at Fair Value $27,100,000,000 (up from $23,100,000,000 year-over-year, up from $26,700,000,000 quarter-over-quarter); growth reflects ongoing investment activity.
Debt to Equity Ratio 0.98 times (down from 0.99 times quarter-over-quarter); slight decrease indicates conservative leverage.
Total Available Liquidity $6,800,000,000; strong liquidity position supports ongoing investment opportunities.
Dividend per Share $0.48; marks the sixty-third consecutive quarter of stable or increasing dividends.
Weighted Average Yield on Debt and Other Income Producing Securities 11.1% (down from 11.1% quarter-over-quarter); decline reflects changes in market base rates.
Weighted Average LTM EBITDA Growth 12% (up from 11% quarter-over-quarter); indicates strong performance across portfolio companies.
Non-Accrual Rate at Cost 1.5% (down from 1.7% quarter-over-quarter); reflects improved credit quality.
Non-Accrual Rate at Fair Value 0.9% (down from 1.0% quarter-over-quarter); indicates strong portfolio health.
Loan to Value Ratio Low 40% range; reflects conservative leverage among portfolio companies.
Taxable Income Spillover $883,000,000 or $1.29 per share available for distribution to stockholders in 2025.
Gross Commitments: Committed $3,500,000,000 in gross commitments during the first quarter, a 54% increase compared to the same period last year.
Market Positioning: The direct lending market remains stable compared to liquid markets, with opportunities for market share growth as banks become more cautious.
Liquidity Position: Maintained strong liquidity with nearly $6,800,000,000 available.
Non-Accrual Loans: Non-accrual loans and lower risk rated credits at historically low levels.
Portfolio Health: Portfolio companies reported double-digit organic LTM EBITDA growth, with a low average loan-to-value ratio of around 40%.
Leadership Transition: Cort Schnabel will take over as CEO, succeeding Kip DeVeer, who has led the company for ten years.
Dividend Declaration: Declared a $0.48 per share quarterly dividend for Q2 2025, marking the 63rd consecutive quarter of stable or increasing dividends.
Market Volatility: Increased volatility and tightening credit conditions in the market have led to a significant drop in new transaction activity, as banks have become more cautious in committing capital.
Competitive Pressures: The direct lending market remains open, but there is a risk that some market participants may pause on launching new M&A processes, potentially leading to slower overall M&A activity.
Tariff Exposure: A mid single-digit percentage of portfolio companies are exposed to higher tariffs, particularly those importing from high tariff countries, which could impact their financial performance.
Economic Factors: Concerns about potential recession risks and inflation dampening consumer demand may lead to companies delaying capital allocation decisions.
Portfolio Management: The company is proactively assessing economic impacts on portfolio companies and is prepared to respond quickly to potential tariff changes, indicating a focus on risk management.
Non-Accrual Loans: While non-accrual loans are at historically low levels, there is ongoing monitoring of portfolio health, especially in sectors like veterinary office roll-ups, which may face challenges.
Liquidity and Leverage: The company maintains a strong liquidity position with nearly $6.8 billion available, but must manage rising costs of liabilities as debt maturities approach.
Investment Commitments: Committed $3.5 billion in gross commitments during Q1 2025, a 54% increase year-over-year.
Liquidity Position: Maintained strong liquidity with nearly $6.8 billion available for new investments.
Portfolio Health: Portfolio companies reported double-digit organic LTM EBITDA growth, with a low average loan-to-value ratio of 40%.
Market Positioning: Positioned to capitalize on market share opportunities in direct lending as banks become more cautious.
Dividend Stability: Declared a $0.48 per share quarterly dividend for Q2 2025, marking the 63rd consecutive quarter of stable or increasing dividends.
Core Earnings: Reported core earnings of $0.50 per share for Q1 2025, with expectations of stable interest income in Q2.
Taxable Income Spillover: Estimated $883 million or $1.29 per share available for distribution to stockholders in 2025.
Debt to Equity Ratio: Ended Q1 2025 with a debt to equity ratio of 0.98 times, indicating conservative leverage.
Future Outlook: Confident in navigating future market conditions, with expectations of continued strong performance and potential portfolio realized gains.
Quarterly Dividend: Declared a $0.48 per share quarterly dividend for the second quarter of 2025.
Consecutive Dividends: This marks the 63rd consecutive quarter of delivering stable or increasing regular quarterly dividends.
Taxable Income Spillover: Estimated $883,000,000 or $1.29 per share available for distribution to stockholders in 2025.
Share Repurchase Program: None
The earnings call summary and Q&A indicate a positive outlook for Ares Capital Corporation. The company anticipates increased market activity and investment opportunities, strong portfolio performance, and dividend stability. The Q&A session revealed no significant risks, with management displaying confidence in their strategies. The positive sentiment is further supported by the company's involvement in large-scale transactions and the recovery of transaction activity. Despite some vague responses, the overall sentiment remains positive, suggesting a likely stock price increase in the short term.
The earnings call summary and Q&A session indicate a stable financial performance with positive growth in investment commitments and portfolio quality. Despite some concerns over non-accrual rates, management's confidence in navigating market conditions and maintaining strong liquidity is reassuring. The dividend stability and strong core earnings further enhance the positive outlook. Although management avoided forward guidance on some aspects, the strategic focus and market positioning suggest a positive sentiment overall.
The earnings call presents a mixed picture: while there are positive elements such as a stable dividend and increased investment activity, the decline in core EPS and GAAP net income raises concerns. The Q&A section highlights management's confidence in navigating volatility and minimal exposure to tariffs, but the lack of clear guidance on potential risks tempers optimism. The absence of a share repurchase program and the stable dividend signal a cautious approach. Overall, the sentiment is balanced, leading to a neutral prediction for the stock price movement.
The earnings call presents mixed signals. Financial performance shows declines in core EPS and net income, but there is growth in gross commitments and total portfolio value. The company maintains strong liquidity and a stable dividend, but lacks a share repurchase program. The Q&A reveals minimal exposure to tariffs and a strong dividend outlook, yet management's unclear responses on certain risks raise concerns. Overall, these factors suggest a neutral sentiment, with no strong catalysts for significant stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.